ID: ALA4581801

Max Phase: Preclinical

Molecular Formula: C12H12N2O3

Molecular Weight: 232.24

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C1CC(NC(=O)Cc2ccccc2)C(=O)N1

Standard InChI:  InChI=1S/C12H12N2O3/c15-10(6-8-4-2-1-3-5-8)13-9-7-11(16)14-12(9)17/h1-5,9H,6-7H2,(H,13,15)(H,14,16,17)

Standard InChI Key:  ZTMDMWMWWGOUHX-UHFFFAOYSA-N

Associated Targets(Human)

Cereblon/Casein kinase I alpha 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cereblon/Aiolos 164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cereblon isoform 4 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 232.24Molecular Weight (Monoisotopic): 232.0848AlogP: -0.24#Rotatable Bonds: 3
Polar Surface Area: 75.27Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.19CX Basic pKa: CX LogP: -0.16CX LogD: -0.17
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.71Np Likeness Score: -0.48

References

1. Heim C, Pliatsika D, Mousavizadeh F, Bär K, Hernandez Alvarez B, Giannis A, Hartmann MD..  (2019)  De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives.,  62  (14): [PMID:31251063] [10.1021/acs.jmedchem.9b00454]

Source